Activation of Akt leads to a significant reduction in E-cadherin expression and to nuclear localization of SNAI1, suggesting a role for the PI3K/Akt signaling pathway in the shift from E-cadherin to N-cadherin expression and in EMT progression in cancer [6,7]. The gene discussed is CDH1; the disease is cancer.